Cellectar Biosciences, Inc. (CLRB) stock
CLRBNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.01−0.13 (-11.40%)
Close on Nov 16, 2026Market cap $9.55MP/E –Yield –
Cellectar Biosciences enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Cellectar Biosciences's enterprise value was -$24.01M on Nov 11, 2026, against -$1.09M a year earlier. Over the last 5 years it ranged from -$24.06M to $73.00M, with a median of -$2.17M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | -$24.01M | – |
| 2025 | Dec 31, 2025 | -$3.14M | – |
| 2024 | Dec 31, 2024 | -$22.13M | -360.7% |
| 2023 | Dec 29, 2023 | $8.49M | – |
| 2022 | Dec 30, 2022 | -$7.34M | -3281.4% |
| 2021 | Dec 31, 2021 | $230.59K | -99.4% |
| 2020 | Dec 31, 2020 | $36.94M | +372.3% |
| 2019 | Dec 31, 2019 | $7.82M | – |
| 2018 | Dec 31, 2018 | -$9.81M | -177.0% |
| 2017 | Dec 29, 2017 | $12.75M | +1312.5% |
| 2016 | Dec 30, 2016 | $902.43K | -72.4% |
| 2015 | Dec 31, 2015 | $3.27M | -73.0% |
| 2014 | Dec 31, 2014 | $12.13M | -27.1% |
| 2013 | Dec 31, 2013 | $16.65M | -34.1% |
| 2012 | Dec 31, 2012 | $25.27M | +135.3% |
| 2011 | Dec 30, 2011 | $10.74M | – |
See a number that looks wrong?